Deficiency of cholesteryl ester transfer protein: Description of the molecular defect and the dissociation of cholesteryl ester and triglyceride transport in plasma

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 17, Issue 12, 1997, Pages 3433-3441

  Ritsch, Andreas ^a   Drexel, Heinz ^b   Amann, Franz W ^b   Pfeifhofer, Christa ^a   Patsch, Josef R ^a  

^a UNIVERSITY OF INNSBRUCK   (Austria)

^b UNIVERSITY HOSPITAL ZURICH   (Switzerland)

Author keywords

Cholesteryl ester transfer protein; HDL; Hyperalphalipoproteinemia; Mutations; Triglycerides

Indexed keywords

CHOLESTEROL ESTER; CHYLOMICRON; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN; TRIACYLGLYCEROL; VERY LOW DENSITY LIPOPROTEIN;

AGED; ALLELE; ARTICLE; ATHEROSCLEROSIS; CASE REPORT; CATABOLISM; DISEASE ASSOCIATION; EXON; FEMALE; GENE AMPLIFICATION; GENE MUTATION; HUMAN; HYPERCHOLESTEROLEMIA; HYPERLIPIDEMIA; HYPERTENSION; LIPOPROTEIN BLOOD LEVEL; MUTATION; PRIORITY JOURNAL; STOP CODON;

EID: 0031457897     PISSN: 10795642     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.ATV.17.12.3433     Document Type: Article

References (21)

1. Albers JJ, Tollefson JH, Chen CH, Steinmetz A. Isolation and characterization of human plasma lipid transfer proteins. Arteriosclerosis. 1984;4:49-58.
2. Jarnagin AS, Kohr W, Fielding CJ. Isolation and specificity of a Mr 74.000 cholesteryl ester transfer protein from human plasma. Proc Natl Acad Sci USA. 1987;84:1854-1857.
3. Barter PJ, Hopkins G, Calvert GD. Transfers and exchanges of esterified cholesterol between plasma lipoproteins. Biochem J. 1982;208:1-7.
4. Hesler CB, Swenson TL, Tall AR. Purification and characterization of human cholesteryl ester transfer protein. J Biol Chem. 1987;262:2275-2282.
5. Morton RE Zilversmit DB. Purification and characterization of lipid transfer protein(s) from human lipoprotein-deficient plasma. J Lipid Res. 1982;23:1058-1067.
6. Brown ML, Inazu A, Hesler CB, Agellon LB, Mann C, Whitlock ME, Marcel YL, Milne RW, Koizumi J, Mabuchi H, Takeda R, Tall AR. Molecular basis of lipid transfer protein deficiency in a family with increased high-density lipoproteins. Nature. 1989;342:448-451.
7. Gotoda T, Kinoshita M, Shimano H, Harada K, Shimada M, Ohsuga J, Teramoto T, Yazaki Y, Yamada N. Cholesteryl ester transfer protein deficiency caused by a nonsense mutation detected in the patient's macrophage mRNA. Biochem Biophys Res Commun. 1993;194:519-524.
8. Inazu A, Jiang X, Haraki T, Yagi K, Kamon N, Koizumi J, Mabuchi H, Takeda R, Takata K, Moriyama Y, Doi M, Tall A. Genetic cholesteryl ester transfer protein deficiency caused by two prevalent mutations as a major determinant of increased levels of high density lipoprotein cholesterol. J Clin Invest. 1994;94:1872-1882.
9. Sakai N, Santamarina-Fojo S, Yamashita S, Matsuzawa Y, Brewer Jr HB. Exon 10 skipping caused by intron 10 splice donor site mutation in cholesteryl ester transfer protein gene results in abnormal downstream splice site selection. J Lipid Res. 1996;37:2065-2073.
10. Arai T, Yamashita S, Sakai N, Hirano K, Okada S, Ishigami M, Maruyama T, Yamane M, Kobayashi H, Nozaki S, Funahashi T, Kameda-Takemura K, Nakajima N, Matsuzawa Y. A novel nonsense mutation (G181x) in the human cholesteryl ester transfer protein gene in Japanese hyperalphalipoproteinemic subjects. J Lipid Res. 1996;37:2145-2154.
11. Castelli WP, Doyle JT, Gordon T, Harnes CG, Hjortland MC, Hulley SB, Kagan A, Zukel WJ. HDL-cholesterol and other lipids in coronary heart disease: The cooperative lipoprotein phenotyping study. Circulation. 1977;55:767-772.
12. Gordon DJ, Probstfield JL, Garrison RJ, Neaton JD, Castelli WP, Knoke JD, Jacobs DRJ, Bangdiwala S, Tyroler HA. High-density lipoprotein cholesterol and cardiovascular disease. Four prospective American studies. Circulation. 79:8-15.
13. Miller GJ, Miller NE. Plasma high density lipoprotein concentration and development of ischemic heart disease. Lancet. 1975;i:16-20.
14. Inazu A, Brown ML, Hesler CB, Agellon LB, Koizumi J, Takata K, Maruhama H, Mabuchi H, Tall AR. Increased high-density lipoprotein levels caused by a common cholesteryl-ester transfer protein gene mutation. N Engl J Med. 1990;323:1234-1238.
15. Patsch JR, Karlin JB, Scott LW, Smith LC, Gotto AMJ. Inverse relationship between blood levels of high density lipoprotein subfraction 2 and the magnitude of postprandial lipemia. Proc Natl Acad Sci USA. 1983;80:1449-1453.
16. Patsch JR. Triglyceride-rich lipoproteins and atherosclerosis. Atherosclerosis. 1994;110:S23-S26.
17. Behr SR, Patsch JR, Forte T, Bensadoun A. Plasma lipoprotein changes resulting from immunologically blocked lipolysis. J Lipid Res. 1981;22:443-451.
18. Miesenböck G, Hölzl B, Föger B, Brandstätter E, Paulweber B, Sandhofer F, Patsch JR. Heterozygous lipoprotein lipase deficiency due to a missense mutation as the cause of impaired triglyceride tolerance with multiple lipoprotein abnormalities. J Clin Invest. 1993;91:448-455.
19. Nagele U, Hagele EO, Sauer G, Wiedemann P, Lehman E, Wahlefeld AW, Gruber W. Reagent for the enzymatic determination of serum total triglycerides with improved lipolytic efficiency. J Clin Chem Clin Biochem. 1984;22:165-174.
20. Siedel J, Hagele EO, Ziegenhorn J, Wahlefeld AW. Reagent for the enzymatic determination of serum total cholesterol with improved lipolytic efficiency. Clin Chem. 1983;29:1075-1080.
21. 2+ precipitation. Clin Chem. 1982;28:1574. Abstract.